EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive
Recent news

Myeloma Patients Europe has participating along with 13 European Patient organisations in the statement calling on European institutions to adopt appropriate measures to incorporate meaningful involvement of patients in EU cooperation on health technology assessment (HTA).

Patients and their organisations are convinced that changes need to be made to the legislation before it is adopted to guarantee an adequate involvement of patients in all HTA activities (joint consultations, early dialogues, scoping and assessments), which is essential to help HTA assessors determine the relative efficacy and safety of health technologies.

The joint statement contents four points explaining those aspects in which patient involvement can make a difference in the HTA process. Read the full document here.







Recent news

» MPE Publishes 2021: Year in Review

» ASH 2021| over 50% of myeloma patients reach minimal residual disease negativity with Isatuximab in combination with RVd

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy